ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Medicago Plans Vaccine Facility

by Marc S. Reisch
May 25, 2015 | APPEARED IN VOLUME 93, ISSUE 21

Medicago, a maker of plant-based vaccines and therapeutics, says it will build a $245 million production complex in Quebec City. To be built in the Estimauville Innovation Park and completed in 2019, the 474,000-sq-ft facility will also house the company’s main office and R&D activities. The facility will enable the firm to hire 200 people in addition to the 180 it already employs in Quebec City.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment